Ignite Creation Date:
2024-05-06 @ 3:25 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04629404
Status:
COMPLETED
Last Update Posted:
2020-11-16
First Post:
2020-11-05
Brief Title:
A Clinical Trial to Evaluate the PharmacodynamicsPharmacokinetics and Safety of LY03003 in Early PD Patients
Sponsor:
Luye Pharma Group Ltd
Organization:
Luye Pharma Group Ltd
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Clinical Trial to Evaluate the PharmacodynamicsPharmacokinetics and Safety of Multiple Intramuscular Doses of LY03003 in Patients With Early Parkinsons Disease
Status:
COMPLETED
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Clinical Trial to Evaluate the PharmacodynamicsPharmacokinetics and Safety of LY03003 in Early PD Patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None